|
Advisory Committee on Blood Safety and AvailabilityPresentations - August 2004Review of Advisory Committee Recommendations
DHHS BASIS Blood Monitoring
National Response Plan and Emergency Support Function #8
Activities of the AABB Interorganizational Task Force
National Blood Reserve, Proof of Concept Using the ASWBPL
AUpdate on the Ad Council Initiative
Give Life Foundation
Update on TRALI and the Working Group of NHLBI
Review of TRALI Consensus Meeting in Canada
Plasma Therapeutic Industry Economics
Role of Reimbursement in Therapeutic Plasma Treatments
Consumer Access, Immune Deficiency Foundation
Licensure Issues of New Advances in Replacement Products for Rare Bleeding Disorders
FDA's Current Thinking on Future Bacterial Detection Field Study Design
AABB's Task Force on Detection of Bacterial Contamination of Platelet Products Status
Whole Blood Derived Platelets Stored as a Pool: A Randomized Block Non-Inferiority Trial
Epidemiology of HBV and Programs on Prevention
Review of BPAC Discussion and FDA's Current Thinking on HBV Minipool NAT
Hepatitis B Virus Nucleic Acid Amplification Technology: Potential Uses at a Blood Center
Yield and Cost-effectiveness of HBV DNA Screening using Minipool or Individual NAT
|
Last Revised: October 15, 2004